Natura &Co Holding S.A.

BOVESPA:NTCO3 Stock Report

Market Cap: R$25.2b

Natura &Co Holding Valuation

Is NTCO3 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NTCO3 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: NTCO3 (R$18.62) is trading below our estimate of fair value (R$22.72)

Significantly Below Fair Value: NTCO3 is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for NTCO3?

Other financial metrics that can be useful for relative valuation.

NTCO3 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.9x
Enterprise Value/EBITDA15.5x
PEG Ration/a

Price to Sales Ratio vs Peers

How does NTCO3's PS Ratio compare to its peers?

The above table shows the PS ratio for NTCO3 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average4.2x
A090430 Amorepacific
2.3x13.7%₩7.5t
A051900 LG H&H
1x3.4%₩5.9t
2367 Giant Biogene Holding
10.9x22.9%HK$41.5b
4527 Rohto PharmaceuticalLtd
2.7x6.1%JP¥710.9b
NTCO3 Natura &Co Holding
1x10.9%R$25.2b

Price-To-Sales vs Peers: NTCO3 is good value based on its Price-To-Sales Ratio (1x) compared to the peer average (4.2x).


Price to Earnings Ratio vs Industry

How does NTCO3's PE Ratio compare vs other companies in the Global Personal Products Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a13.2%
n/an/an/a
No. of CompaniesPS048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a13.2%
n/an/an/a
No more companies

Price-To-Sales vs Industry: NTCO3 is good value based on its Price-To-Sales Ratio (1x) compared to the Global Personal Products industry average (1.7x).


Price to Sales Ratio vs Fair Ratio

What is NTCO3's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NTCO3 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate NTCO3's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst NTCO3 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentR$18.62
R$19.61
+5.3%
9.6%R$23.00R$17.00n/a11
Mar ’25R$16.62
R$19.38
+16.6%
10.7%R$23.00R$16.50n/a11
Feb ’25R$16.29
R$19.25
+18.1%
10.7%R$23.00R$16.50n/a11
Jan ’25R$16.89
R$18.61
+10.2%
12.6%R$23.00R$15.00n/a11
Dec ’24R$16.93
R$18.43
+8.8%
13.7%R$23.00R$15.00n/a11
Nov ’24R$12.58
R$18.52
+47.2%
14.6%R$24.00R$15.00n/a11
Oct ’24R$14.56
R$19.27
+32.3%
16.0%R$25.00R$15.00n/a12
Sep ’24R$15.37
R$18.78
+22.2%
18.7%R$25.00R$14.30n/a12
Aug ’24R$18.34
R$18.69
+1.9%
19.3%R$25.00R$14.00n/a12
Jul ’24R$16.74
R$17.45
+4.2%
15.7%R$23.00R$14.00n/a13
Jun ’24R$14.39
R$17.00
+18.1%
18.8%R$23.00R$12.20n/a12
May ’24R$11.06
R$16.47
+48.9%
21.3%R$24.00R$11.00n/a15
Apr ’24R$13.20
R$16.59
+25.7%
20.8%R$22.00R$11.00n/a13
Mar ’24R$14.49
R$17.32
+19.5%
27.0%R$28.80R$11.00R$16.6214
Feb ’24R$14.00
R$17.32
+23.7%
27.1%R$28.80R$11.00R$16.2914
Jan ’24R$11.61
R$18.58
+60.0%
31.0%R$30.00R$11.00R$16.8913
Dec ’23R$11.33
R$20.69
+82.6%
31.3%R$35.80R$11.00R$16.9314
Nov ’23R$14.77
R$22.77
+54.2%
32.0%R$36.00R$12.00R$12.5814
Oct ’23R$14.73
R$26.68
+81.1%
38.6%R$49.00R$13.00R$14.5616
Sep ’23R$14.43
R$30.43
+110.8%
46.5%R$70.00R$13.00R$15.3716
Aug ’23R$15.34
R$31.49
+105.3%
44.5%R$70.00R$16.00R$18.3415
Jul ’23R$13.23
R$33.45
+152.8%
43.2%R$70.00R$16.00R$16.7414
Jun ’23R$16.58
R$33.41
+101.5%
42.1%R$70.00R$20.00R$14.3913
May ’23R$18.59
R$37.75
+103.1%
33.9%R$70.00R$24.00R$11.0612
Apr ’23R$28.05
R$40.42
+44.1%
30.3%R$70.00R$28.00R$13.2012
Mar ’23R$23.15
R$44.17
+90.8%
33.5%R$74.00R$27.00R$14.4912

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.